Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for SomaLogic's Cardiovascular Disease in Type 2 Diabetes Test: A CPV® Randomized Controlled Trial

NCT05237271 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT05237271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05237271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for SomaLogic's Cardiovascular Disease in Type 2 Diabetes Test: A CPV® Randomized Controlled Trial
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2022
Completion date
August 15, 2022
Enrollment
251 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, type 2 diabetes